Medicine Description esmorap 20 mg
esmorap 20 mg capsules is a medication that belongs to the class of proton pump inhibitors (PPIs). It functions by selectively inhibiting the H+/K+-ATPase enzyme system located on the gastric parietal cells. This action effectively blocks the final step of gastric acid production, leading to a decrease in stomach acid secretion. By reducing acidity, esmorap aids in alleviating symptoms associated with gastroesophageal reflux disease (GERD) and promotes healing of erosive esophagitis caused by prolonged acid exposure. Additionally, it mitigates the risk of peptic ulcers, particularly in patients undergoing long-term NSAID therapy, by creating a less acidic environment in the stomach.
Indications and Uses of esmorap 20 mg capsules
- Gastroesophageal reflux disease (GERD)
- Erosive esophagitis caused by acid-mediated damage
- Peptic ulcers, including those related to nonsteroidal anti-inflammatory drug (NSAID) use
- Pathological hypersecretion conditions, such as Zollinger-Ellison syndrome
Side Effects of esmorap 20 mg capsules
- Nausea
- Headache
- Diarrhea
- Abdominal pain
- Flatulence
- Dizziness
Storage and Handling
Store esmorap 20 mg capsules in a cool, dry place away from direct sunlight. Keep out of reach of children and ensure the container is tightly closed.
Patient Advice and Precautions
Patients are advised to take esmorap capsules as prescribed and to not exceed the recommended duration of therapy without consulting a healthcare provider. It is important to inform your physician of any other medications being taken, as esomeprazole can interact with certain drugs. Individuals should be aware of the potential for vitamin B12 deficiency with prolonged use and monitor for signs of adverse effects.